Cilostazol
- Product NDC
- 62135-986
- 11-digit product format
- 621350986
- Labeler code
- 62135
- Product ID
- 62135-986_3dfa32ae-94ba-4885-e063-6394a90a9333
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cilostazol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA077021
- Marketing category
- ANDA
- Marketing start
- 2004-11-23
- Substance
- CILOSTAZOL
- Active strength
- 100 mg/1
- Pharmacologic classes
- Phosphodiesterase 3 Inhibitor [EPC], Phosphodiesterase 3 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cilostazol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CILOSTAZOL | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | N7Z035406B |
| Rxcui | 242461, 242462 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-986-60 | Cilostazol | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-986-60 | 62135098660 | 60 TABLET in 1 BOTTLE (62135-986-60) | 60 tablet | 2025-08-27 | No | No | Historical |